1. Home
  2. BWEN vs INKT Comparison

BWEN vs INKT Comparison

Compare BWEN & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadwind Inc.

BWEN

Broadwind Inc.

N/A

Current Price

$2.08

Market Cap

51.0M

Sector

Industrials

ML Signal

N/A

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

N/A

Current Price

$8.55

Market Cap

57.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BWEN
INKT
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.0M
57.6M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
BWEN
INKT
Price
$2.08
$8.55
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$6.00
$35.00
AVG Volume (30 Days)
141.9K
157.7K
Earning Date
03-11-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
360.00
N/A
EPS
0.23
N/A
Revenue
$146,785,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$17.37
N/A
P/E Ratio
$8.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$6.66
52 Week High
$4.15
$76.00

Technical Indicators

Market Signals
Indicator
BWEN
INKT
Relative Strength Index (RSI) 36.16 36.09
Support Level $1.88 $6.80
Resistance Level $2.25 $12.64
Average True Range (ATR) 0.15 0.80
MACD -0.00 -0.18
Stochastic Oscillator 25.81 1.03

Price Performance

Historical Comparison
BWEN
INKT

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: